New degradome markers in children and adults with chronic lung disease

O. Tselousova, G. Korytyna, T. Victorova (Ufa, Russian Federation)

Source: Annual Congress 2012 - COPD inflammation and genes
Session: COPD inflammation and genes
Session type: Poster Discussion
Number: 4799
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Tselousova, G. Korytyna, T. Victorova (Ufa, Russian Federation). New degradome markers in children and adults with chronic lung disease. Eur Respir J 2012; 40: Suppl. 56, 4799

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of lung functions in patients of chronic liver disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


Consequences of chronic lung diseases for young adults
Source: Annual Congress 2011 - From chronic lung diseases in childhood to COPD
Year: 2011


Lung function in school age children with chronic lung disease of prematurity
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015


New markers of early functional disorders in healthy smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 249s
Year: 2004

Different inflammatory phenotypes in adults and children with acute asthma
Source: Eur Respir J 2011; 38: 567-574
Year: 2011



Annual lung function changes in young patients with chronic lung disease
Source: Eur Respir J 2002; 19: 886-891
Year: 2002



Novel therapies for severe asthma in children and adults
Source: Breathe, 14 (1) 59; 10.1183/20734735.018917
Year: 2018



Functional status in patients with chronic lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 652s
Year: 2007

The impact of COVID-19 on children with chronic suppurative lung disease
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



Assessments of respiratory function in early lung disease in infants and young children with CF
Source: Annual Congress 2012 - Cournand Lecture followed by Hot Topic "Early intervention in CF: why, when and how?"
Year: 2012


MBW and MRI as sensitive markers of stable CF lung disease and at exacerbation in children and adolescents
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012


Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Mycobacterial lung disease in adults
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Worsening of functional limitations and health status in patients with chronic obstructive pulmonary (COPD) as compared to patients with other chronic illnesses in a national sample of US adults
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005

Biochemical markers of bone remodeling in children with chronic lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006

High prevalence of COPD among adults with heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019



Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007



Epidemiologic basis for differential diagnosis of obstructive lung disease in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 66s
Year: 2003